Journals / KONURALP TIP DERGİSİ / 2022 / Cilt: 14 - Sayı: 3

Investigation of Serum Folate-Receptor-1 Levels in Patients with Non-Small Cell Lung Cancer

Küçük Hücreli Dışı Akciğer Kanserli Hastalarda Serum Folat-Reseptör-1 Düzeylerinin Araştırılması

Pages
526–532
Publication Date
2022-10-20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Result: In NSCLC patients sFOLR1 levels were significantly higher(p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Histopathological overexpression of folate receptor-1 (FOLR1) involved in folate transport in cell growth has been reported in various cancers.
📊
Key Findings & Data:Increased serum FOLR1(sFOLR1) has also been reported in epithelial ovarian cancer.
💡
Conclusion & Impact:Result: In NSCLC patients sFOLR1 levels were significantly higher(p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Folat Reseptörü 1 (FOLR1) · Karsinoembriyonik Antijen (CEA) · Küçük Hücreli Olmayan Akciğer Kanseri (KHDAK)

Abstract

Objective: Histopathological overexpression of folate receptor-1 (FOLR1) involved in folate transport in cell growth has been reported in various cancers. Increased serum FOLR1(sFOLR1) has also been reported in epithelial ovarian cancer. The aim was to investigate sFOLR1 levels in non-small cell lung cancer (NSCLC) patients and the response prediction of the standard chemotherapy targeting folic acid metabolism. Method: In this prospective study, sFOLR1 levels were investigated in 30 healthy individuals and 60 patients with stage4 malign metastatic NSCLC before and after standard chemotherapy. The commercial immunoassay (ELISA) kit used for analysis of sFOLR1. Serum carcinoembryonic antigen (CEA), vitamin B12, and folate levels were also investigated. Result: In NSCLC patients sFOLR1 levels were significantly higher(p

Özet

Amaç: Hücre büyümesinde folat taşınmasında rol oynayan folat reseptörü-1'in (FOLR1) histopatolojik aşırı ekspresyonu çeşitli kanserlerde bildirilmiştir. Artmış serum FOLR1(sFOLR1) epitelyal yumurtalık kanserinde de rapor edilmiştir. Amaç, küçük hücreli dışı akciğer kanseri (KHDAK) hastalarında sFOLR1 düzeylerini ve folik asit metabolizmasını hedefleyen standart kemoterapinin tahminini yanıtını araştırmaktı. Gereç ve Yöntem: Bu prospektif çalışmada, standart kemoterapi öncesi ve sonrası evre4 malign metastatik KHDAK'li 60 hasta ve 30 sağlıklı bireyde sFOLR1 düzeyleri araştırıldı. Ticari immünolojik test (ELISA) kiti sFOLR1'in analizi için kullanıldı. Serum karsinoembriyonik antijen (CEA), vitamin B12 ve folat düzeyleri de araştırıldı. Bulgular: KHDAK hastalarında sFOLR1 seviyeleri sağlıklı bireylere göre anlamlı derecede yüksekti(p

🔖

Cite This Article

ÇELİKKOL, A., ŞEBER, E. S., GÜZEL, S., YOLCU, A., YETİŞYİĞİT, T., YİLMAZ, A. (2022). Investigation of Serum Folate-Receptor-1 Levels in Patients with Non-Small Cell Lung Cancer. KONURALP TIP DERGİSİ, Cilt: 14 - Sayı: 3, 526–532. https://ajindex.com/articles/686630

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Dong Y, Zheng X, Yang Z, Sun M, Zhang G, An X, et al. Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer. J Cancer Res Ther. 2016;12(5):C34–6
  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Vol. 68, CA: A Cancer Journal for Clinicians. 2018. p. 394–424
  3. Nunez MI, Behrens C, Woods DM, Lin H, Suraokar M, Kadara H, et al. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and mutation. Journal of Thoracic Oncology Lippincott Williams and Wilkins; 2012 p. 833–40
  4. Ji W, Weng X, Xu D, Cai S, Lou H, Ding L. Non-small cell lung cancer cells with deficiencies in homologous recombination genes are sensitive to PARP inhibitors. Biochem Biophys Res Commun. 2020;522(1):121–6
  5. Kelemen LE. The role of folate receptor α in cancer development, progression and treatment: Cause, consequence or innocent bystander? International Journal of Cancer. John Wiley & Sons, Ltd; 2006. 119: 243–50
  6. Kurosaki A, Hasegawa K, Kato T, Abe K, Hanaoka T, Miyara A, et al. Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression. Int J Cancer. 2016;138(8):1994–2002
  7. Driver BR, Barrios R, Ge Y, Haque A, Tacha D, Cagle PT. Folate receptor a expression level correlates with histologic grade in lung adenocarcinoma. Arch Pathol Lab Med. 2016;140(7):682–5
  8. Hartmann LC, Keeney GL, Lingle WL, Christianson TJH, Varghese B, Hillman D, et al. Folate receptor overexpression is associated with poor outcome in breast cancer. Int J Cancer. 2007;121(5):938–42
  9. Shia J, Klimstra DS, Nitzkorski JR, Low PS, Gonen M, Landmann R, et al. Immunohistochemical expression of folate receptor α in colorectal carcinoma: patterns and biological significance. Hum Pathol. 2008;39(4):498–505
  10. Senol S, Ceyran AB, Aydin A, Zemheri E, Ozkanli S, Kösemetin D, et al. Folate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia. Int J Clin Exp Pathol. 2015;8(5):5633–41
  11. Omote S, Takata K, Tanaka T, Miyata-Takata T, Ayada Y, Noujima-Harada M, et al. Overexpression of folate receptor alpha is an independent prognostic factor for outcomes of pancreatic cancer patients. Med Mol Morphol. 2018;51(4):237–43
  12. Leung F, Dimitroma